[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-04", "acceptance_datetime": "2025-11-04T21:03:18Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001104659-25-106259", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001104659-25-106259/files/crvs-20250930x10q_htm.xml", "financials": {"income_statement": {"operating_income_loss": {"value": -10572000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -10157000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 2090000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_before_equity_method_investments": {"value": -9834000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_loss_from_continuing_operations_before_tax": {"value": -9834000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 82836369.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "basic_earnings_per_share": {"value": -0.12, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -0.12, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "diluted_average_shares": {"value": 82836369.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -9834000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "depreciation_and_amortization": {"value": 28000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss_attributable_to_parent": {"value": -10157000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_equity_method_investments": {"value": -323000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "operating_expenses": {"value": 10572000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "nonoperating_income_loss": {"value": 415000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -10157000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 8454000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -2618000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 360000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -2618000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -11824000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -9566000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -9566000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -11824000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 360000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"fixed_assets": {"value": 221000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 8074000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 632000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 13530000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 13309000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_assets": {"value": 1244000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "assets": {"value": 80474000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 6100000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 71768000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 8706000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 1974000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "cash": {"value": 65700000.0, "unit": "USD", "label": "Cash", "order": 210}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 80474000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 66944000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 71768000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -10069000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -10069000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -10069000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-07", "acceptance_datetime": "2025-08-07T20:02:56Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-25-010755", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-25-010755/files/crvs-20250630x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 35770000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 9692000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -5777000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -20301000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -20301000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 9692000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 35770000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -5777000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -7892000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -7998000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"diluted_average_shares": {"value": 77774344.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "depreciation_and_amortization": {"value": 29000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "income_loss_before_equity_method_investments": {"value": -7609000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "basic_average_shares": {"value": 77774344.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_expenses": {"value": 10260000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_equity_method_investments": {"value": -389000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "research_and_development": {"value": 7873000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -7609000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_earnings_per_share": {"value": -0.1, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 2358000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -7998000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -7998000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.1, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "nonoperating_income_loss": {"value": 2262000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -7998000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -7998000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -10260000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}, "balance_sheet": {"other_current_liabilities": {"value": 5368000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 3137000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "cash": {"value": 74400000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_liabilities": {"value": 8505000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 13681000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 89461000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 249000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 80228000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 13432000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 9233000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_assets": {"value": 1380000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "assets": {"value": 89461000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 80228000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 75780000.0, "unit": "USD", "label": "Current Assets", "order": 200}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-08", "acceptance_datetime": "2025-05-08T20:06:05Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-25-006966", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-25-006966/files/crvs-20250331x10q_htm.xml", "financials": {"income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": 15193000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "nonoperating_income_loss": {"value": -25115000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 9922000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 72126496.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_earnings_per_share": {"value": -0.13, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_parent": {"value": 15193000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -9922000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "depreciation_and_amortization": {"value": 22000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "research_and_development": {"value": 7453000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 2447000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_equity_method_investments": {"value": -539000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "diluted_average_shares": {"value": 75152514.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_available_to_common_stockholders_basic": {"value": 15193000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": 15193000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": 0.21, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": 15732000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_before_equity_method_investments": {"value": 15732000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": 15193000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": 15227000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 279000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -8263000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -8263000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -3741000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 279000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 4243000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 4243000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -3741000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "balance_sheet": {"other_current_liabilities": {"value": 7971000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 13782000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "cash": {"value": 44200000.0, "unit": "USD", "label": "Cash", "order": 210}, "liabilities": {"value": 10113000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 59438000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_assets": {"value": 1291000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 1308000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 49325000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 13947000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 165000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 9279000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 45491000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 49325000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 59438000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -550000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -12663000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -12663000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"other_noncurrent_assets": {"value": 14349000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 68907000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 151000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "cash": {"value": 52000000.0, "unit": "USD", "label": "Cash", "order": 210}, "equity_attributable_to_parent": {"value": 32568000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 32568000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 14500000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_assets": {"value": 2407000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 2582000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 32820000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 36339000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 937000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 35402000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 54407000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 68907000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -6083000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 4060000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 18608000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -6083000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -8465000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -8465000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 18608000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 4060000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"other_operating_expenses": {"value": 2096000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_before_equity_method_investments": {"value": -9939000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "depreciation_and_amortization": {"value": 35000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "diluted_earnings_per_share": {"value": -0.16000000000000003, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss": {"value": -12113000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 2471862.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_earnings_per_share": {"value": -0.16000000000000003, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -8105000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 2471862.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -9939000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 8105000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_equity_method_investments": {"value": -2174000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 5974000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -9939000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -12113000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -12113000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-12", "acceptance_datetime": "2024-11-12T21:03:37Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-24-015306", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-24-015306/files/crvs-20240930x10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -39600000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -39600000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -39600000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"other_current_assets": {"value": 1221000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 42921000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 15894000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 58815000.0, "unit": "USD", "label": "Assets", "order": 100}, "cash": {"value": 41700000.0, "unit": "USD", "label": "Cash", "order": 210}, "other_current_liabilities": {"value": 43923000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 46406000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 171000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 58815000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 15723000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 12409000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 610000, "unit": "USD", "label": "Wages", "order": 730}, "equity": {"value": 12409000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 46406000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 1873000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "income_statement": {"operating_income_loss": {"value": -7255000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -40217000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -0.6, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -40217000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -39535000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 7255000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "depreciation_and_amortization": {"value": 20000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_before_equity_method_investments": {"value": -39535000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "diluted_earnings_per_share": {"value": -0.6, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 2013000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_average_shares": {"value": 66701086.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss": {"value": -40217000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -39535000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_average_shares": {"value": 66701086.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_equity_method_investments": {"value": -682000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "research_and_development": {"value": 5222000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 50000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -10161000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -6321000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 50000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -3890000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -6321000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -10161000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -3890000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-06", "acceptance_datetime": "2024-08-06T20:02:30Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-24-011076", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-24-011076/files/crvs-20240630x10q_htm.xml", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 64561000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 16111000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "wages": {"value": 683000, "unit": "USD", "label": "Wages", "order": 730}, "fixed_assets": {"value": 192000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 64561000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_assets": {"value": 1058000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 48258000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 13335000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 51226000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 1213000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 13335000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 11439000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 51226000.0, "unit": "USD", "label": "Equity", "order": 1400}, "cash": {"value": 47200000.0, "unit": "USD", "label": "Cash", "order": 210}, "noncurrent_assets": {"value": 16303000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"income_loss_before_equity_method_investments": {"value": -3685000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_loss_from_continuing_operations_before_tax": {"value": -3685000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 1800000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 59710265.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_equity_method_investments": {"value": -577000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "operating_expenses": {"value": 5935000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -4262000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -4262000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 59710265.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -4262000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 4114000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_earnings_per_share": {"value": -0.07, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -4262000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "depreciation_and_amortization": {"value": 21000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "diluted_earnings_per_share": {"value": -0.07, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -5935000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -17504000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -5481000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 2221000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -17504000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 25206000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 2221000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 25206000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -5481000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -4342000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -4262000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-07", "acceptance_datetime": "2024-05-07T21:16:16Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-24-007093", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-24-007093/files/crvs-20240331x10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -6009000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -5701000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -5701000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "depreciation_and_amortization": {"value": 23000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "diluted_earnings_per_share": {"value": -0.12, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_before_equity_method_investments": {"value": -5937000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "research_and_development": {"value": 4075000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -5701000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_equity_method_investments": {"value": 236000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "operating_expenses": {"value": 6253000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -5701000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -5937000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 2155000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_income_loss": {"value": -6253000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -5701000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.12, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "basic_average_shares": {"value": 49038582.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 49038582.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}}, "cash_flow_statement": {"net_cash_flow": {"value": 0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 5164000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -5157000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -5157000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -7000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 5164000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -7000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "balance_sheet": {"wages": {"value": 589000, "unit": "USD", "label": "Wages", "order": 730}, "other_current_liabilities": {"value": 4522000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 40084000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 40084000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 33364000.0, "unit": "USD", "label": "Equity", "order": 1400}, "cash": {"value": 22100000.0, "unit": "USD", "label": "Cash", "order": 210}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 213000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 33364000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 6720000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 751000, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 1609000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 17233000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 6720000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 22851000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 17020000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "financials": {"income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -6653000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 341482, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_average_shares": {"value": 341482, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_income_loss": {"value": -5651000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.13000000000000006, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": -6653000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "depreciation_and_amortization": {"value": 77000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "income_loss_from_continuing_operations_before_tax": {"value": -6653000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 5651000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 1575000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 3999000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_earnings_per_share": {"value": -0.13000000000000006, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -6653000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -6653000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"equity": {"value": 38684000.0, "unit": "USD", "label": "Equity", "order": 1400}, "wages": {"value": 684000, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 17361000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "cash": {"value": 27100000.0, "unit": "USD", "label": "Cash", "order": 210}, "other_current_liabilities": {"value": 4660000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_assets": {"value": 856000, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 6869000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 38684000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 1525000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_liabilities": {"value": 6869000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 45553000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 236000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 27956000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 45553000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 17597000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -7485000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -5167000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -2318000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -7485000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -2318000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -5167000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -6177000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 476000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -6177000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-07", "acceptance_datetime": "2023-11-07T21:02:38Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-23-017981", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-23-017981/files/crvs-20230930x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 335000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 335000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 17546000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 17546000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -5434000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 12447000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 12447000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -5434000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.12, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_average_shares": {"value": 48971246.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "research_and_development": {"value": 3965000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 1565000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 5560000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -6000000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -6000000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -6000000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 48971246.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "depreciation_and_amortization": {"value": 30000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss_available_to_common_stockholders_basic": {"value": -6000000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -5560000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.12, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -6000000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"accounts_payable": {"value": 1404000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 44289000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 51942000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 5144000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 264000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 7299000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "wages": {"value": 751000, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_liabilities": {"value": 354000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 7653000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 33094000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "cash": {"value": 32200000.0, "unit": "USD", "label": "Cash", "order": 210}, "other_current_assets": {"value": 894000, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities_and_equity": {"value": 51942000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 44289000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 18848000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 18584000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -6075000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -6075000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -6075000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-08", "acceptance_datetime": "2023-08-08T20:02:33Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-23-013914", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-23-013914/files/crvs-20230630x10q_htm.xml", "financials": {"income_statement": {"operating_expenses": {"value": 5622000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 1618000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_earnings_per_share": {"value": -0.14, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "depreciation_and_amortization": {"value": 36000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "income_loss_from_continuing_operations_after_tax": {"value": -6503000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -6503000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -5622000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -6503000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -6503000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_average_shares": {"value": 47497414.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 47497414.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -6503000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.14, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 3968000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -7437000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -6503000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow": {"value": -1996000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -4289000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 7516000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -4289000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 7516000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -1996000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -5223000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -5223000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"equity_attributable_to_parent": {"value": 49483000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 804000, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 49483000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 19837000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 58041000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 294000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 58041000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 37910000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 8558000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_assets": {"value": 910000, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_liabilities": {"value": 7858000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "cash": {"value": 37000000.0, "unit": "USD", "label": "Cash", "order": 210}, "accounts_payable": {"value": 2098000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 20131000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 4956000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-08", "acceptance_datetime": "2023-05-08T20:02:35Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-23-008503", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-23-008503/files/crvs-20230331x10q_htm.xml", "financials": {"income_statement": {"net_income_loss_attributable_to_parent": {"value": -7873000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.17, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "research_and_development": {"value": 4594000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 46556178.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -6574000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "depreciation_and_amortization": {"value": 57000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss": {"value": -7873000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -7873000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 1923000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -7873000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.17, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 6574000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 46556178.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -7873000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "cash_flow_statement": {"net_cash_flow": {"value": -3505000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 4000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -3505000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 4602000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 4000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 4602000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -8111000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -8111000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"current_assets": {"value": 35551000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 22646000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 9330000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 6225000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 58197000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 658000, "unit": "USD", "label": "Wages", "order": 730}, "cash": {"value": 34500000.0, "unit": "USD", "label": "Cash", "order": 210}, "accounts_payable": {"value": 1407000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_assets": {"value": 1051000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": 48867000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 22316000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 48867000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 58197000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 8290000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 330000, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -7873000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -7744000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "financials": {"balance_sheet": {"other_noncurrent_assets": {"value": 24223000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "cash": {"value": 42300000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_assets": {"value": 43664000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 353000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 56115000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 56115000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 24576000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 68240000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 12125000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 1373000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_assets": {"value": 1364000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "wages": {"value": 1113000.0, "unit": "USD", "label": "Wages", "order": 730}, "assets": {"value": 68240000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 10752000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 7663000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 1976000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -9816000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "basic_earnings_per_share": {"value": -0.20999999999999996, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 1186000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_earnings_per_share": {"value": -0.27, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss": {"value": -9816000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 4080000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -9816000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -9816000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -9816000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -5666000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_average_shares": {"value": 0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 5666000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -7547000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -3882000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 11429000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 11429000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -3882000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -7547000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -9186000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 630000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -9186000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-016233", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-016233/files/crvs-20220930x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": 0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -6929000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 3889000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -6929000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 3889000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 3040000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 3040000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.26, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -12473000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 12473000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_average_shares": {"value": 46553511.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_average_shares": {"value": 46553511.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -14831000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -14831000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.32, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -14831000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -14831000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "other_operating_expenses": {"value": 2108000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -14831000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 10365000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -16363000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -16363000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -16363000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"accounts_payable": {"value": 4227000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 51272000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 64681000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 28629000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 447000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 15667000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 8408000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 1689000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 29076000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 80348000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 13978000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "wages": {"value": 1343000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 80348000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_assets": {"value": 1672000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_parent": {"value": 64681000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "cash": {"value": 49600000.0, "unit": "USD", "label": "Cash", "order": 210}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-08", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-012619", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-012619/files/crvs-20220630x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 3140000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -6123000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 2983000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -6123000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 3140000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 2983000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -10011000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -8363000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"assets": {"value": 92541000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 10156000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 58885000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 6251000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 2650000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "cash": {"value": 56700000.0, "unit": "USD", "label": "Cash", "order": 210}, "equity_attributable_to_parent": {"value": 80386000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 33129000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_assets": {"value": 2185000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "fixed_assets": {"value": 527000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 92541000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "wages": {"value": 1255000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities": {"value": 12155000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 33656000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 80386000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "income_statement": {"basic_average_shares": {"value": 46553511.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -8363000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -8363000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -8363000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_earnings_per_share": {"value": -0.18, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -7013000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -8363000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 46553511.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -0.18, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -8363000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 4923000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 2090000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 7013000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-05", "acceptance_datetime": "2022-05-05T20:12:09Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-007374", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-007374/files/crvs-20220331x10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -8179000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -8297000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"research_and_development": {"value": 5100000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -0.18, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -0.18, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -8297000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 2313000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 46553511.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -7413000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -8297000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -8297000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 7413000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -8297000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 46553511.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -8297000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -25574000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 31998000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -6424000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -25574000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 31998000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -6424000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 89722000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 11568000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 6129000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "cash": {"value": 62900000.0, "unit": "USD", "label": "Cash", "order": 210}, "accounts_payable": {"value": 2189000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "wages": {"value": 947000, "unit": "USD", "label": "Wages", "order": 730}, "other_current_assets": {"value": 1467000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "assets": {"value": 101290000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 64367000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 9265000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 89722000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 101290000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 36923000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 364000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 36559000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -6856000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -6856000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 18000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -1999000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -1999000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -8837000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 18000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -8837000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -9236000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 4788000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -0.2, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -0.2, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -9236000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_before_equity_method_investments": {"value": -9236000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss": {"value": -9236000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -6810000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -9236000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 6810000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 2022000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -9236000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "balance_sheet": {"liabilities_and_equity": {"value": 109455000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 37692000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 97162000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 2601000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 71312000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "cash": {"value": 69500000.0, "unit": "USD", "label": "Cash", "order": 210}, "assets": {"value": 109455000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 9692000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 38143000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 6281000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 97162000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 1846000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_current_assets": {"value": 1812000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 1565000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 12293000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 451000, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -8742000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -8742000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 494000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-01", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-013913", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-013913/files/crvs-20210930x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 3471000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -8425000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 18334000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 3471000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -8425000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 18334000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 13380000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 13380000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -9047000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -10673000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 2056000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -0.24, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_before_equity_method_investments": {"value": -10673000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "diluted_earnings_per_share": {"value": -0.24, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -10673000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -10673000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -10673000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 9047000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 6991000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -10673000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -10685000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -10685000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -10685000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"accounts_payable": {"value": 2334000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 14175000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 40027000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 78757000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 40566000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 2870000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "cash": {"value": 76300000.0, "unit": "USD", "label": "Cash", "order": 210}, "liabilities_and_equity": {"value": 119323000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 105148000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_assets": {"value": 2457000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_current_liabilities": {"value": 7562000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 105148000.0, "unit": "USD", "label": "Equity", "order": 1400}, "wages": {"value": 1409000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_liabilities": {"value": 11305000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 539000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 119323000.0, "unit": "USD", "label": "Assets", "order": 100}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-02", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-009818", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-009818/files/crvs-20210630x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 15242000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 11216000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 11216000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 13811000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -12647000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 15242000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -12647000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 13811000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -10371000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -11752000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"other_noncurrent_assets": {"value": 39627000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 96403000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 12360000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 647000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 12991000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 69120000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 109394000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "cash": {"value": 66500000.0, "unit": "USD", "label": "Cash", "order": 210}, "accounts_payable": {"value": 2865000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 1629000.0, "unit": "USD", "label": "Wages", "order": 730}, "assets": {"value": 109394000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 40274000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 7866000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 96403000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_assets": {"value": 2620000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}}, "income_statement": {"operating_income_loss": {"value": -11290000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 9106000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -11752000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -11752000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_before_equity_method_investments": {"value": -11752000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "basic_earnings_per_share": {"value": -0.28, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 2184000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_earnings_per_share": {"value": -0.28, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_parent": {"value": -11752000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 11290000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -11752000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -11752000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-04-29", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-005258", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-005258/files/crvs-20210331x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": 28649000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 4846000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -8787000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 4846000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 28649000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 32590000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 32590000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -8787000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -11580000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -11578000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -11580000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -11580000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -11580000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 11483000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 3253000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -11483000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.34, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -11580000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.34, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -11580000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 8230000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_before_equity_method_investments": {"value": -11580000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}}, "balance_sheet": {"liabilities": {"value": 14851000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "cash": {"value": 68000000.0, "unit": "USD", "label": "Cash", "order": 210}, "noncurrent_assets": {"value": 40427000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 94385000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 109236000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "wages": {"value": 1601000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_assets": {"value": 68809000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 94385000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 13916000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_noncurrent_assets": {"value": 39658000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_assets": {"value": 809000, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 109236000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 769000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 4910000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 7405000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001626971", "sic": "2834", "tickers": ["CRVS"], "company_name": "Corvus Pharmaceuticals, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": 27339000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -8000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": 27339000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "other_operating_expenses": {"value": 2688000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_before_equity_method_investments": {"value": 27347000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": 27347000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": 27347000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": 27347000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -9879000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": 27347000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": 27347000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 9879000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 7191000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"other_current_liabilities": {"value": 6457000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 72148000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 1232000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 2225000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 85529000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 13381000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_assets": {"value": 1036000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_liabilities": {"value": 12149000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "cash": {"value": 44300000.0, "unit": "USD", "label": "Cash", "order": 210}, "assets": {"value": 85529000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 40193000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 45336000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 3467000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 39287000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 906000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 72148000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "cash_flow_statement": {"net_cash_flow": {"value": -6521000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 463000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 1223000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -6521000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -8207000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 463000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 1223000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -8207000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}]